Clinical Practice Guideline for Management of Primary Aldosteronism: What is New in the 2016 Update?
- PMID: 28018978
- PMCID: PMC5175479
- DOI: 10.16966/2380-548X.129
Clinical Practice Guideline for Management of Primary Aldosteronism: What is New in the 2016 Update?
Abstract
Primary Aldosteronism is the single most common cause of secondary hypertension and is associated with increased target organ injury. The Endocrine Society has recently released the updated Clinical Practice Guideline for Primary Aldosteronism entitled "The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline". We review the updated Clinical Practice Guideline, highlighting the new recommendations and the implications that they may have in clinical practice. The recognition by the Endocrine Society's Task Force that Primary Aldosteronism is a public health issue and that the population at risk for screening should be significantly expanded will surely have an impact in the clinical practice which hopefully will translate in better detection, diagnosis and treatment of patients with Primary Aldosteronism.
Keywords: Adrenocorticotrophic hormone; Aldosterone-producing adenoma; Primary Aldosteronism.
References
-
- Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101:1889–1916. - PubMed
-
- Bollag WB. Regulation of aldosterone synthesis and secretion. Compr Physiol. 2014;4:1017–1055. - PubMed
-
- Connell JM, MacKenzie SM, Freel EM, Fraser R, Davies E. A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocr Rev. 2008;29:133–154. - PubMed
-
- Spat A, Hunyady L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev. 2004;84:489–539. - PubMed
-
- Jaisser F, Farman N. Emerging Roles of the Mineralocorticoid Receptor in Pathology: Toward New Paradigms in Clinical Pharmacology. Pharmacol Rev. 2016;68:49–75. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources